代表性论文: 

1.      Niu G#, Cai X, Yang Y, Jing J, Zhang D, Wang X,Wang Z, Liu D, Liu G, Wang Y, Wang Y, Pan Y*.Association of Cardiovascular-Kidney-Syndrome and Brain Macrostructure andMicrostructure Injury: A Prospective Cohort Study. Diabetes Obes Metab. 2026;28(5):4148-4161. (IF=5.7)

2.      Li L#, Pan Y#, Yan H, WuY, Sun F, Shi X, Zhou Y*, Wang Y*.Predictive role of baseline serum creatinine-to-cystatin C ratio for renaldysfunction incidence in patients with acute ischemic stroke. BMC Nephrol.2026;27(1):172. (IF=2.4)

3.      Xu Z#, Chen W, Wang X, Gao Y, Johnston SC,Amarenco P, Bath PM, Yan H, Wang T, Yang Y, Zhou Q, Wang M, Wang Y, Pan Y*.Association between free fatty acid and 3-month prognosis of acute ischemicstroke. J Stroke Cerebrovasc Dis.2026;35(4):108589. (IF=1.8)

4.      Chen H#, Zhang A#, Chen W, Cai X, ZhouM, Li S, Jing J, Wei T, Wang Y, Pan Y*, Wang Y*. Association of Sleep Duration WithIntracranial Atherosclerosis and Cerebral Small Vessel Disease: A Mediation byMetabolic Factors. CNS Neurosci Ther. 2026;32(2):e70797. (IF=5.0)

5.      Wang M#, Cai X, Gao P, Yang Y, Ding Y, Zhang Z,Sun J, Zhang Y, Liu D, Wang Y, Wang Y, Pan Y*.Associations of Accelerated Biological Aging With the Presence and LongitudinalProgression of Cerebral Small Vessel Disease. Neurology. 2026;106(9):e214818. (IF=8.5)

6.      Chen Y#, Jiang L#, Yao D, Liu D, PanY*, Wang Y*. Aquaporin-4deficiency induced white matter injury via upregulated complement component 3in cerebral small vessel disease. J Neuroinflammation. 2026;23(1):65.(IF=9.3)

7.      Li Y#, Liu D, Yang Y, Cai X, Sun J, Pan Y*,Wang Y*. Heterogeneity of cerebral small vessel disease based onimaging markers in a community-based population. Stroke Vasc Neurol.2026:svn-2025-004504. (IF=4.4)

8.      Zhang Z#, Zhang D#, Cai X, Yang Y, SunJ, Niu G, Xu Z, Jing J, Wang Y, Wang Y, Pan Y*.Association of Systemic Inflammatory Markers With Cerebral Small Vessel DiseaseProgression: A Community-Based Prospective Study. Neurology.2026;106(6):e214711. (IF=9.0)

9.      Zhang A#, Chen H#, Chen W, Cai X, ZhouM, Li S, Jing J, Wei T, Wang Y, Wang Y*, PanY*. Association of sleep duration with cognitive impairment:A mediation by metabolic factors and intracranial atherosclerosis. JAlzheimers Dis. 2026;109(1):362-371. (IF=3.1)

10.   Xia Z#, Cai X, Yang Y, Li S, Wang M, Wang X, WeiT, Wang Y, Wang Y*, Pan Y*. EffectModification by Total Bilirubin on the Association Between Hypertension andCerebral Small Vessel Disease. J Stroke.2026;28(1):85-96. (IF=8.6)

11.   Yang Y#, Yang J#, Gao Y, Chen W, WangX, Yan H, Wang T, Wang Y, Pan Y*, Wang Y*. Dual Antiplatelet Therapy After Ischemic StrokeStratified by Intracranial or Extracranial Atherosclerotic Stenosis. Ann Neurol. 2026;99(2):429-436. (IF=8.1)

12.   Xia Z#, Jiang L, Cai X, Jing J, Li S, Wang M, WangS, Wang X, Wei T, Wang Y, Pan Y*, Wang Y*.Associations between endothelial inflammatory markers and cerebral small vesseldisease in a community-based population. IntJ Stroke. 2026;21(4):539-551.(IF=6.3)

13.   Pan Y#, Miao Z, Huo X*. Intra-Arterial TenecteplaseAfter Successful Endovascular Therapy for Acute Stroke-Reply. JAMA.2025;334(21):1950-1951.

14.   Zuo L#, Kua Z#, Wang X, Low A, Cai X,Li S, Wang M, Wang Y, Dong Y*, Pan Y*. SexDifferences in the Impact of Atherosclerotic Cardiovascular Risk Burden onCognitive Health. J Am Heart Assoc. 2025:14(17):e042741. (IF=5.0)

15.   Xia Z#, Gao Y, Chen W, Johnston SC, Amarenco P,Bath PM, Wang X, Yan H, Wang T, Yang Y, Zhang Y, Wang M, Jing J, Wang C, WangY, Wang Y, Pan Y*. Dual Antiplatelet Therapy inPatients With Metabolic Syndrome After Mild Ischemic Stroke or TransientIschemic Attack. J Am Heart Assoc. 2025:14(15):e041449. (IF=5.0)

16.   Chen Y#, Jiang L#, Gao Y, Chen W, YanH, Wang T, Yang Y, Yao D, Liu D, Pan Y*, Wang Y*.CYP2C19 Genotype and Efficacy of Clopidogrel Initiated Between 24 to 72 Hoursfor Ischemic Stroke. Stroke.2025;56(11):3108-3117. (IF=7.8)

17.   Qiu B#, Cai X#, Zhou L#,Wang X, Li S, Wang N, Jiang L, Jing J, Wei T, Wang Y, Pan Y*,Wang Y*. Association of Serum Thromboinflammatory Biomarkers WithAtherosclerotic Plaques and Burden in a Community-Based Population. ArteriosclerThromb Vasc Biol. 2025;45(9):1672-1682. (IF=7.4)

18.   Wang Z#, Li S#, Liu D, Cai X, Jing J,Wang Y, Wei T, Pan Y*, Wang Y*. CoronaryAtherosclerosis and Subclinical Cerebral Small Vessel Disease: A RobustAssociation Beyond Intracranial Atherosclerosis and Cardiac Systolic Function.J Am Heart Assoc. 2025;14(15):e042081. (IF=5.0)

19.   Wang M#, Pu S#, Jin A, Johnston SC,Bath PM, Dong Q, Xu A, Yan H, Meng X, Yuan B, Jing J, Lin J, Jiang Y, Xie X, PanY*, Wang Y*. Effect of Stroke Severity onEfficacy and Safety of Indobufen versus Aspirin in Patients with Moderate toSevere Stroke: Results from the INSURE Randomized Clinical Trial. J Atheroscler Thromb. 2025; 32: 1586-1600. (IF=2.8)

20.   Jiang N#, Ji H#, Guan Z#, PanY#, Deng C#, Guo Y#, Liu D#,Chen T#, Wang S, Wu Y, Yang D, Ran AR, Hamzah H, Chee ML, Yin C,Thinggaard BS, Pedersen FN, Peng Q, Quek TC, Goh JHL, Singh S, Abd Raof AS,Lee-Boey JWS, Lu Y, Huang S, Shu J, Yu S, Jin Y, Li T, Qin Y, Wang J, Yang X,Hu T, Wang Z, Zhao Y, Lee S, Wei X, Zheng H, Li Y, Shen J, Zhou Y, Lin S, Wu C,Dai R, Ruan L, Hogg RE, Wright D, Wang YX, Zheng Y, Tan GSW, Sabanayagam C, BaoY, Zhang C, Zhang P, Zou W, Guo M, Yang X, McKay GJ, Grauslund J, Lim LL, Li Z,Cheung CY, Tham YC, Cheng CY, Wang Y*, Dai Q*, Jia W*,Li H*, Sheng B*, Wong TY*. A deep learningsystem for detecting silent brain infarction and predicting stroke risk. Nat Biomed Eng. 2025;9(11):1907-1919. (IF=26.8)

21.   Liu D#, Yan H#, Gao Y, Chen W, JohnstonC, Amarenco P, Bath PM, Wang X, Wang M, Wang T, Yang Y, Jing J, Wang C, Wang Y,Pan Y*, Wang Y*. Effect of history ofhypertension on efficacy of clopidogrel-aspirin in ischemic stroke. Int J Stroke. 2025; 20(8):1021-1030. (IF=6.3)

22.   Wang Y#, Pan Y#, Wang X,Gao Y, Chen W, Johnston SC, Bath PM, Amarenco P, Gao C, Wang Y, Liao X*,Wang Y*. Relationship Between Neutrophil Count and 90-Day Outcomesand Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Strokeor Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial. J Am Heart Assoc. 2025: 14(14):e040492. (IF=5.0)

23.   Li H#, Cheng M, Gao Y, Yan H, Wang Y, Johnston SC,Bath PM, Amarenco P, Yang Y, Chen W, Wang Y, Pan Y*,Wang Y*. Does the Burden of CSVD Modify the Efficacy of DualAntiplatelet Therapy? A Post Hoc Analysis of the INSPIRES Trial. Stroke. 2025; 56(6):1376-1387.(IF=7.8)

24.   Zhou Q#, Gao Y, Chen W, Johnston SC, Amarenco P,Bath PM, Wang X, Yan H, Wang T, Yang Y, Zhang Y, Yang Q, Wang M, Jing J, WangC, Wang Y, Wang Y*, Pan Y*. Efficacy andSafety of Dual Antiplatelet Treatment up to 72 Hours in Acute Ischemic StrokeStratified by Glycemic Status. AnnNeurol. 2025; 98(1):174-182. (IF=8.1)

25.   Yang Y#, Cai X#, Zhou M, Chen Y, Pi J,Zhao M, Shi Y, Jing J, Chen W, Yan H, Meng X, Wang Y, Pan Y*,Wang Y*. Association of Left Ventricular Function With CerebralSmall Vessel Disease in a Community-Based Population. CNS Neurosci Ther. 2025;31(2):e70226. (IF=4.8)

26.   Zhang R#, Yao D#, Cai X, Zhang Y, YangY, Li S, Jing J, Wang S, Wang Y, Pan Y*, Wang Y*.Prevalence and Risk Factors of Covert Brain Infarction: a Community-basedCross-sectional Study. Int J Stroke.2025;20(5):611-622. (IF= 6.3)

27.   Wang M#, Yan H, Zhang Y, Zhou Q, Meng X, Lin J,Jiang Y, Pan Y*, Wang Y*. Acceleratedbiological aging increases the risk of short- and long-term stroke prognosis inpatients with ischemic stroke or TIA. eBioMedicine. 2025;111:105494.(IF= 9.7)

28.   Zhang Y#, Wang X#, Gao Y, Chen W,Johnston SC, Amarenco P, Bath PM, Yan H, Wang T, Yang Y, Zhou Q, Wang M, JingJ, Wang C, Wang Y, Wang Y*, Pan Y*. DualAntiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by RiskProfile: A Post Hoc Analysis. Stroke. 2025;56(1):46-55. (IF=7.8)

29.   Zhang Y#, Pan Y#, Yan H,Meng X, Lin J, Wang M, Li H, Xu Q, Chen P, Wang A, Zhou Y*, Wang Y*.Prognostic Impact of 1-Year Changes in Creatinine- and Cystatin C-BasedEstimated Glomerular Filtration Rate After Stroke on 5-Year Outcomes: InsightsFrom the Third China National Stroke Registry. J Am Heart Assoc. 2025:14(2):e037579.(IF=5.0)

30.   Zhang Y#, Wang M#, Cai X, Jin A, JingJ, Wang S, Meng X, Li S, Zhou Q, Wang X, Wei T, Wang Y, Pan Y*.Associations of non-insulin-based insulin resistanceindices with presence and extent of multiterritorial atherosclerosis: Across-sectional study. J Clin Lipidol. 2025;19(1):60-71. (IF=3.6)

31.   Zhou Q#, Zhu W#, Cai X, Jing J, Wang M,Wang S, Jin A, Meng X, Wei T, Wang Y, Pan Y*. Obesityand brain volumes: mediation by cardiometabolic and inflammatory measures. StrokeVasc Neurol. 2025;10(2):e003045. (IF=4.4)

32.   Zhou Q, Cai X, Jin A, Jing J, Wang M, Wang S, Mei L, Meng X,Shan L, Wei T, Wang Y, Liu L*, Pan Y*.Associations between adipose tissue-specific insulin resistance andatherosclerotic plaques and burden in community-based population. Neuroepidemiology. 2025;59(4):302-312. (IF=3.2)

33.   Wang D#, Pan Y#, Cai X#,Jing J, Yan H, Wang S, Meng X, Mei L, Zhang Y, Li S, Wei T, Zhou Y*,Wang Y*. Prevalence and Associated Factors ofAtherosclerotic Plaque and Stenosis in Renal Arteries: A Community-Based Study.Angiology. 2025; 76(8):751-758. (IF=2.6)

34.   Liu Y#, Zhao J#, Gao Y, Chen W,Johnston SC, Bath PM, Amarenco P, Yan H, Wang X, Yang Y, Wang T, Wang Y, PanY*, Wang Y*. Clopidogrel and Aspirin InitiatedBetween 24 to 72 Hours for Mild Ischemic Stroke: A Subgroup Analysis of theINSPIRES Randomized Clinical Trial. JAMANetw Open.2024;7(9):e2431938. (IF=10.5)

35.   Guan L#, Han S, Johnston SC, Bath PM, Amarenco P,Yang Y, Wang T, Jing J, Wang C, Gao Y, Chen W, Yan H, Wang X, Wang Y, Wang Y, PanY*. Duration of Benefit and Risk of Dual AntiplateletTherapy up to 72 Hours After Mild Ischemic Stroke and Transient IschemicAttack. Neurology. 2024; 103(7):e209845. (IF=7.7)

36.   Liu D#, Zhang Y#, Cai X, Yang Y, WangS, Mei L, Jing J, Li S, Wang M, Meng X, Wei T, Wang Y, Wang Y*, PanY*. Associations of 10-year atherosclerotic cardiovasculardisease risk scores with cerebral small vessel disease: the PolyvasculaREvaluation for Cognitive Impairment and vaScular Events (PRECISE) study. AgeAgeing. 2024;53(7):afae161. (IF= 6.0)

37.   Zhou M#, Zhou Y#, Jing J, Wang M, JinA, Cai X, Meng X, Liu T, Wang Y, Wang Y*, Pan Y*.Insulin Resistance and White Matter Microstructural Abnormalities inNondiabetic Adult: A Population-Based Study. Int J Stroke. 2024;19(10):1162-1171. (IF= 6.3)

38.   Zhang Y#, Liu D#, Cai X, Jin A, Mei L,Jing J, Wang S, Meng X, Li S, Wang M, Yan H, Wei T, Wang Y*, PanY*. Associations of life's essential 8 with extent ofmulti-territorial atherosclerotic plaques and stenosis: a cross-sectionalstudy. BMC Geriatr. 2024;24(1):503. (IF=3.4)

39.   Zhou M#, Mei L#, Jing J, Yang Y, Cai X,Meng X, Jin A, Lin J, Li S, Li H, Wei T, Wang Y, Wang Y*, PanY*. Blood Pressure Partially Mediated the Association ofInsulin Resistance and Cerebral Small Vessel Disease: A Community-Based Study. J Am Heart Assoc. 2024;13(5):e031723. (IF=5.0)

40.   Meng Y#, Wang S#, Zhu W, Wang T, Liu D,Wang M, Pi J, Liu Y, Zhuo Z, Pan Y*, Wang Y*.Association of Mean Upper Cervical Spinal Cord Cross-Sectional Area WithCerebral Small Vessel Disease: A Community-Based Cohort Study. Stroke. 2024; 55(3):687-695. (IF=7.8)

41.   Liu D#, Cai X, Yang Y, Wang S, Mei L, Jing J, LiS, Wang M, Chen Y, Meng X, Wei T, Wang Y, Wang Y*, Pan Y*.Association between Life's Essential 8 and Cerebral Small Vessel Disease. StrokeVasc Neurol. 2024; 9(5):481-489. (IF=4.4)

42.   Pan Y#, Huo X, Jin A, Nguyen TN,Ma G, Tong X, Zhang X, Gao F, Ma N, Mo D, Ren Z, Wang Y, Miao Z*.Cost-effectiveness of endovascular therapy for acute ischemic stroke with largeinfarct in China. J Neurointerv Surg. 2024; 16(5):453-458. (IF=4.5)

43.   Yang Y#, Cai X#, Zhou M, Chen Y, Pi J,Zhao M, Shi Y, Wang S, Jing J, Chen W, Meng X, Wang Y, Pan Y*,Wang Y*. Prevalence and Risk Factors of Cerebral Small VesselDisease from a Population-Based Cohort in China. Neuroepidemiology. 2023; 57(6):413-422. (IF=3.2)

44.   Zhang Y#, Xia Z#, Cai X, Su X, Jin A,Mei L, Jing J, Wang S, Meng X, Li S, Wang M, Wei T, Wang Y*, He Y*,Pan Y*. Association of metabolicdysfunction-associated fatty liver disease with systemic atherosclerosis: acommunity-based cross-sectional study. Cardiovasc Diabetol. 2023;22(1):342. (IF=8.5)

45.   Zhou Q#, Yan H, Jin A, Meng X, Lin J, Li H, WangY, Pan Y*. Adipose tissue specific insulin resistanceand prognosis of nondiabetic patients with ischemic stroke. Diabetol MetabSyndr. 2023;15(1):246. (IF=3.4)

46.   Cai X#, Sun J#, Jin A, Jing J, Wang S,Mei L, Meng X, Li S, Wei T, Wang Y, Pan Y*.Association of insulin resistance with intra- and extra-cranial atheroscleroticburden in the nondiabetic community population. Neurobiol Dis. 2023;186:106268.(IF=5.1)

47.   Wang Y#, Cai X#, Li H, Jin A, Jiang L,Chen W, Jing J, Mei L, Li S, Meng X, Wei T, Wang Y, Pan Y*,Wang Y*. Association of Intracranial Atherosclerosis with CerebralSmall Vessel Disease in Community-based Population. Eur J Neurol. 2023;30(9):2700–2712. (IF=4.5)

48.   Zhang Y#, Pan Y#, Cai X#,Jing J, Yan H, Wang S, Meng X, Mei L, Zhang Y, Li S, Wei T, Zhou Y*,Wang Y*. Association between Urine Albumin-to-creatinine Ratio andIntracranial Atherosclerotic Plaque in Chinese Adults - Results from thePRECISE Study. J Atheroscler Thromb. 2023;30(12):1828-1837. (IF=3.0)

49.   Tian Y#, Cai X#, Zhou Y, Jin A, Wang S,Yang Y, Mei L, Jing J, Li S, Meng X, Wei T, Liu T, Wang Y, Pan Y*,Wang Y*. Impaired glymphatic system as evidenced by low diffusivityalong perivascular spaces is associated with cerebral small vessel disease: apopulation-based study. Stroke Vasc Neurol. 2023;8(5):413-423. (IF=4.4)

50.   Zhou H#, Chen W, Suo Y, Meng X, Zhao X, Wang M,Liu L, Li H, Pan Y*, Wang Y*. ExternalValidation of the Nelson Equation for Kidney Function Decline in Patients withAcute Ischemic Stroke or Transient Ischemic Attack. Clin Interv Aging.2023; 18: 901-909. (IF=3.5)

51.   Pan Y#, Shen J#, CaiX#, Chen H, Zong G, Zhu W, Jing J, Liu T, Jin A, Wang Y, Meng X,Yuan C*, Wang Y*. Adherence to a healthy lifestyleand brain structural imaging markers. EurJ Epidemiol. 2023;38(6):657-668. (IF= 7.7)

52.   Pan Y#, Meng X#, YuanB, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Jiang Y, Xie X, JinA, Suo Y, Yang H, Feng Y, Zhou Y, Liu Q, Li X, Liu B, Zhu H, Zhao J, Huang X,Li H, Xiong Y, Li Z, Wang Y, Zhao X, Liu L, Wang Y*; INSUREInvestigators. Indobufen versus aspirin in patients with acute ischaemic strokein China (INSURE): a randomised, double-blind, double-dummy, active control,non-inferiority trial. LancetNeurol. 2023; 22(6):485-493. (IF=46.5)

53.   Fang H#, Chen W#, Jin A,Wang M, Yan H, Xiang X, Pan Y*. Effects of geneticallydetermined mineral status on life expectancy: a Mendelian randomization study. ChinMed J (Engl). 2023;136(2):242-244. (IF=7.5)

54.   Tian Y#, Li S#, Yang Y,Cai X, Jing J, Wang S, Meng X, Mei L, Jin A, Yao D, Wei T, Wang Y, Pan Y*,Wang Y*. Associations of deep medullary veins with vascular riskfactors, laboratory indicators, and cerebral small vessel disease: Apopulation-based study. Brain Behav.2023;13(5): e2974. (IF=2.6)

55.   Jin A#, Wang S#, Li J,Wang M, Lin J, Li H, Meng X, Wang Y, Pan Y*. Mediationof systemic inflammation on insulin resistance and prognosis of nondiabeticpatients with ischemic stroke. Stroke.2023; 54(3):759-769. (IF=7.8)

56.   Zhou M#, Wang S#,Jing J, Yang Y, Cai X, Meng X, Mei L, Lin J, Li S, Li H, Wei T, Wang Y, PanY*, Wang Y*. Insulin resistance basedon postglucose load measure is associated with prevalence and burden ofcerebral small vessel disease. BMJ Open Diabetes Res Care. 2022;10(5):e002897.(IF=3.7)

57.   Wang M#, Mei L#,Jin A, Cai X, Jing J, Wang S, Meng X, Li S, Wei T, Wang Y, Pan Y*.Association between Triglyceride Glucose index andAtherosclerotic Plaques and Burden: Findings from a Community-Based Study. CardiovascDiabetol. 2022;21(1):204. (IF=8.5)

58.   Xu Y#, Chen W#, Jiang L,Wang Y, Zhao X, Liu L, Yao D, Guo L, Wang Y, Pan Y*,Wang Y*. Aspirin platelet reactivity on platelet function andclinical outcome in minor stroke or transient ischemic attack. J StrokeCerebrovasc Dis. 2022;31(9):106683. (IF=2.0)

59.   Zhang Y, Jin A, Meng X, Wang M, Li H, Pan Y*,Wang Y*. Association between Diabetes Duration and 1-Year Prognosisof Stroke: A National Registry Study. Brain Behav.2022; 12(9): e2725. (IF=2.6)

60.   Pan Y#, Cai X#, JingJ, Wang S, Meng X, Mei L, Yang Y, Jin A, Yao D, Li S, Li H, Wei T, Wang Y*,Wang Y*. Differential Associations of Lipoprotein(a)Level with Cerebral Large Artery and Small Vessel Diseases. StrokeVasc Neurol. 2022;7: e001625. (IF=4.4)

61.   Liu D#, Cai X#, Yang Y, Wang S, Yao D,Mei L, Jing J, Li S, Yan H, Meng X, Li H, Wei T, Wang Y, Pan Y*,Wang Y*. Associations of Life's Simple 7 with Cerebral Small VesselDisease. Stroke. 2022;53(9):2859-2867.(IF=7.8)

62.   Jing J#, Zhou Y#, Pan Y#,Cai X#, Zhu W, Zhang Z, Li Z, Liu C, Meng X, Cheng J, Wang Y, Li H,Wu Z, Wang S, Niu H, Wen W, Liu T*, Wei T*, Wang Y*,Sachdev PS. Reduced White Matter Microstructural Integrity in Prediabetes andDiabetes: A Population-based Study. eBioMedicine. 2022; 82:104144. (IF=9.7)

63.   Jin A#, WangM#, Chen W, Yan H, Xiang X, Pan Y*. DifferentialEffects of Genetically Determined Cholesterol Efflux Capacity on CoronaryArtery Disease and Ischemic Stroke. Front Cardiovasc Med. 2022; 9:891148.(IF=2.8)

64.    Pan Y#, Jing J#, Cai X#, Jin Z, Wang S, Wang Y,Zeng C, Meng X, Ji J, Li L, Lyu L, Zhang Z, Mei L, Li H, Li S, Wei T*,Wang Y*. Prevalence and Vascular Distribution of MultiterritorialAtherosclerosis Among Community-Dwelling Adults in Southeast China. JAMA Netw Open. 2022;5(6):e2218307. (IF=10.5)

65.    Yao D#, Li S#,Jing J, Cai X, Jin A, Yang Y, Wang S, Meng X, Lin J, Mei L, Li H, Wei T, Wang Y,Pan Y*, Wang Y*. Association of serumcystatin C with cerebral small vessel disease in community-based population. Stroke. 2022;53(10):3123-3132. (IF=7.8)

66.   Jiang L#, CaiX#, Yang Y, Wang S, Jing J, Mei L, Jin A, Li S, Meng X, Li H, Wei T,Wang Y, Pan Y*, Wang Y*. Association ofinflammatory markers with cerebral small vessel disease in community-basedpopulation. J Neuroinflammation.2022;19(1):106. (IF=9.3)

67.  Ma G#, Yu Z#,Jia B, Xian Y, Ren Z, Mo D, Ma N, Gao F, Tong X, Shi X, Li L, Pan Y*,Miao Z*; ANGEL-ACT study group. Time to Endovascular Reperfusion andOutcome in Acute Ischemic Stroke: A Nationwide Prospective Registry inChina. Clin Neuroradiol. 2022;32(4):997-1009. (IF=2.4)

68.   Pan Y,Meng X, Jin A, Johnston SC, Li H, Bath PM, Xie X, Jing J, Lin J, Wang Y,Zhao X, Li Z, Jiang Y, Liu L, Yang H, Cheng J, Wang Z, Wang Y*.Time Course for Benefit and Risk With Ticagrelor and Aspirin in IndividualsWith Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 RandomizedClinical Trial. JAMA Neurol.2022;79(8):739-745.(IF=20.4)

69.   Pan Y#, Meng X#, Chen W, Jing J, Lin J, Jiang Y, Johnston SC,Bath PM, Dong Q, Xu A, Li H,Wang Y*. Indobufen versus aspirin in acute ischaemic stroke(INSURE): rationale and design of a multicentre randomised trial. StrokeVasc Neurol. 2022;7: e001480. (IF=4.4)

70.   Wang Y*#, Pan Y#, Li H, Amarenco P, Denison H, Evans SR, HimmelmannA, James S, Knutsson M, Ladenvall P, Molina CA, Johnston SC*. Timecourse for benefit and risk of ticagrelor and aspirin in acute ischemic strokeor transient ischemic attack. Neurology. 2022; 99(1):e46-e54. (IF=7.7)

71.   Pan Y#, Wangqin R#, Li H, Jin A, Li J, Lin J, Meng X,Xian Y, Laskowitz DT, Wang Y*. LDL-C Levels, Lipid LoweringTreatment and Recurrent Stroke in Minor Ischaemic Stroke or TIA. Stroke VascNeurol. 2022; 7: e001317. (IF=4.4)

72.   Chen W#, YaoD#, Yan H, Wang M, Pan Y*. GeneticallyPredicted Childhood Obesity and Adult Atrial Fibrillation: a MendelianRandomization Study. Nutr Metab Cardiovasc Dis. 2022; 32(4):1019-1026. (IF=3.3)

73.  Zhou M, Li H, Wang Y, Pan Y*, Wang Y*.Causal effect of Insulin Resistance on Small Vessel Stroke and Alzheimer'sDisease: A Mendelian Randomization Analysis. Eur J Neurol. 2022;29(3):698-706.(IF=4.5)

74.  Wang D#,Pan Y#, Li H, Yan H, Meng X, Lin J, Wang H, Matsushita H, Shlipak MG, Zhou Y*, Wang Y*. The Associationbetween Baseline and 3-Month Albuminuria and 1-Year Prognosis of IschemicStroke. Cerebrovasc Dis. 2022;51(1):67-74.(IF=2.2)

75.   Chen W#, Cai X#,Yan H, Pan Y*. Causal Effect of Obstructive SleepApnea on Atrial Fibrillation: A Mendelian Randomization Study. J Am Heart Assoc. 2021;10(23):e022560. (IF=5.0)

76.   Wang Y*#, Pan Y#, Li H, Amarenco P, Denison H, Evans SR, HimmelmannA, James S, Birve F, Ladenvall P, Molina CA, Johnston SC*; THALESInvestigators. Efficacy and safety of ticagrelor and aspirin in patients withmoderate ischemic stroke: an exploratory analysis of the THALES randomizedclinical trial. JAMA Neurol. 2021;78(9):1091-1098.(IF=20.4)

77.   Xiong Y#, Pan Y#,Nogueira RG, Ren Z, Jovin TG, Wang Y*. Treating acute large vesselocclusion stroke: to bridge or not to bridge? Stroke Vasc Neurol. 2021; 6(3):324-327. (IF=4.4)

78.   Pan Y#, Li Z, Li J, Jin A, LinJ, Jing J, Li H, Meng X, Wang Y, Wang Y*. Residual risk and its riskfactors for ischemic stroke with adherence to guideline-based secondary strokeprevention. J Stroke. 2021;23(1):51-60.(IF=6.0)

79.  Pan Y#, Jing J#, Cai X#, Wang Y, Wang S, Meng X, ZengC, Shi J, Ji J, Lin J, Lyu L, Zhang Z, Mei L, Li S, LiS, Zhu W, Li H, Wei T*, Wang Y*. PolyvasculaREvaluation for Cognitive Impairment and vaScular Events (PRECISE)- apopulation-based prospective cohort study: rationale, design and baselineparticipant characteristics. Stroke Vasc Neurol. 2021;6(1):145-151. (IF=4.4)

80.   Pan Y#, Wangqin R#, Li H, Wang Y, Meng X,Johnston SC, Simon T, Lin J, Zhao X, Liu L, Wang D, Wang Y*. F2Rpolymorphisms and clopidogrel efficacy and safety in patients with minor strokeor TIA. Neurology. 2021;96(1):e1-e9. (IF=7.7)

81.   Pan Y, Li H, Wardlaw JM, Wang Y*. A new dawn ofpreventing dementia by preventing cerebrovascular diseases. BMJ. 2020;371:m3692. (IF=93.6)

82.   Fang HJ#, Pan YS#,Wang YJ, Wang CX, Wang YL, Zhong LY*. Prognostic value of admissionhyperglycemia on outcomes of thrombolysis in ischemic stroke patients with orwithout diabetes. Chin Med J (Engl).2020;133(18):2244-2246. (IF=7.5)

83.  Pan Y*, Chen W, Yan H, Wang M,Xiang X. Glycemic Traits and Alzheimer's Disease: A Mendelian RandomizationStudy. Aging (Albany NY). 2020; 12(22): 22688-22699. (IF=3.9)

84.   Chen W#, Wang S#,Lv W, Pan Y*. Causal Associations of InsulinResistance with Coronary Artery Disease and Ischaemic Stroke: A MendelianRandomisation Analysis. BMJ Open Diabetes Res Care. 2020; 8(1). pii: e001217. (IF=3.7)

85.   Yang Y#, Chen W, Meng X, Liu L, Wang Y, Pan Y*,Wang Y*. Impact of Smoking on Platelet Function of Ticagrelor VersusClopidogrel in Minor Stroke or Transient Ischaemic Attack. Eur J Neurol. 2020; 27(5):833-840. (IF=4.5)

86.   Jiang J#, Cai X#, Pan Y*, Yan Y, Zhu H, YangX, Zheng D, Gaisano H, Wei T*, Yan H*. Relationship ofobesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care.2020; 8(1). pii: e000741. (IF=3.7)

87.   Pan Y*, Zhang L, Li Z, Meng X, Wang Y, Li H,Liu L, Wang Y*. Cost-Effectiveness of a Multifaceted Quality ImprovementIntervention for Acute Ischemic Stroke in China. Stroke. 2020;51(4):1265-1271. (IF=7.8)

88.   Wen J#, Cai X#,Zhang J, Jiang J, Li W, Liu G, Wang M, Gaisano HY, Pan Y*,He Y*. Relation of adipose tissue insulin resistance toprediabetes. Endocrine. 2020;68(1):93-102. (IF= 3.0)

89.   Lin J#, Wang Y,Wang Y, Pan Y*. Inflammatory biomarkers and risk ofischemic stroke and subtypes: A 2-sample Mendelian randomization study. Neurol Res. 2020;42(2):118-125. (IF=1.7)

90.   Liu H#, Zheng H#,Wu P, Liu CF, Wang D, Li H, Meng X, Wang Y, Cao Y, Wang Y, Pan Y*.Estimated glomerular filtration rate, anemia and outcomes in patients withischemic stroke. Ann Transl Med. 2020;8(1):2. (IF=3.6)

91.   Pan Y*, Wang Y, Wang Y. Investigationof Causal Effect of Atrial Fibrillation on Alzheimer's Disease: A MendelianRandomization Study. J Am HeartAssoc.2020;9(2):e014889. (IF=5.0)

92.   Liu H#, Meng X#,Liu CF, Wang D, Zheng H, Li H, Liu L, Wang Y, Wang Y, Pan Y*.Higher Hemoglobin A1c Level Is Associated with Poor Outcome of IntracerebralHemorrhage. Front Neurol. 2019; 10:1073.(IF=2.7)

93.   Pan Y*, Li H, Wang Y, Meng X,Wang Y*. Causal Effect of Lp(a) [Lipoprotein(a)] Level on IschemicStroke and Alzheimer Disease: A Mendelian Randomization Study. Stroke. 2019;50(12):3532-3539. (IF=7.8)

94.  Zhu B#, Pan Y*, Jing J, Meng X, ZhaoX, Liu L, Wang Y, Wang Y, Wang Z*. Stress Hyperglycemia and Outcome ofNon-diabetic Patients After Acute Ischemic Stroke. Front Neurol. 2019; 10:1003. (IF=2.7)

95.  Pan Y#, Elm JJ#, LiH, Easton JD, Wang Y, Farrant M, Meng X, Kim AS, Zhao X, Meurer WJ, Liu L,Dietrich D, Wang Y*, Johnston SC*. Outcomes AssociatedWith Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: APooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-DisablingCerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA andMinor Ischemic Stroke (POINT) Trials. JAMANeurol. 2019;76(12):1466-1473. (IF=20.4)

96.  Wang T#, PanY#, Lin J, Anand R, Wang D, Johnston SC, Meng X, Li H, ZhaoX, Liu L, Wang Y, Wang Y*; CHANCE investigators. Influence ofsmoking on CYP2C19 genetic variants and clopidogrel efficacy in patients withminor stroke or TIA. Eur J Neurol. 2019;26(9):1175-1182.(IF=4.5)

97.  Sun S#, PanY#, Bai L, Zhao X, Liu L, Li H, Wang Y, Guo L*,Wang Y*. GWTG Risk Model for All Stroke Types Predicts In-Hospitaland 3-Month Mortality in Chinese Patients with Acute Stroke. J Stroke Cerebrovasc Dis. 2019;28(3):800-806. (IF=2.0)

98.  Pan Y, Chen W, Wang Y*.Prediabetes and outcome of ischemic stroke or transient ischemic attack: asystematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2019; 28(3):683-692. (IF=2.0)

99.  Pan Y, Chen W, Wang Y, Li H, Johnston SC, Simon T, Zhao X, Liu L, Wang D, Meng X,Wang Y*. Association between ABCB1 Polymorphisms and Outcomes ofClopidogrel Treatment in Patients with Minor Stroke or Transient IschemicAttack: Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol. 2019;76(5):552-560. (IF=20.4)

100.Zhu B#, Liu H#,Pan Y#, Jing J, LiH, Zhao X, Liu L, Wang D, Johnston SC, Wang Z, Wang Y*, Wang Y*.Elevated Neutrophil and Presence of Intracranial Artery Stenosis Increase theRisk of Recurrent Stroke. Stroke. 2018;49(10): 2294-2300. (IF=7.8)

101.Zhou Y#, Zhang Y#,Pan Y#, Jing J,Zhao X, Liu L, Wang C, Li H, Yan H, Meng X, Wang Y*, Wang Y*.Insulin Resistance Index from Oral Glucose Tolerance Test Predicts IschemicStroke Outcomes in Non-Diabetic Patients with Different Estimated GlomerularFiltration Rate Strata. Cerebrovasc Dis.2018;46(3-4):140-149. (IF=2.2)

102.Jia Y#, Pan Y#, Ren H, Ji N,Lou F*. Effectiveness and safety of high-voltage pulsedradiofrequency to treat patients with primary trigeminal neuralgia: amulticenter, randomized, double-blind, controlled study. Pain physician. 2018; 21:469-481. (IF=2.6)

103.Pan Y, Jing J, Wang Y, Liu L, WangY, He Y*. Association of Hemoglobin Glycation Index with Outcomes ofAcute Ischemic Stroke in Type 2 Diabetic Patients. Neurol Res. 2018; 40(7):573-580. (IF=1.7)

104.Zhu B#, Pan Y#, Jing J, MengX, Zhao X, Liu L, Wang D, Johnston SC, Li H, Wang Y*, Wang Z*, Wang Y*. Neutrophilcounts, neutrophil ratio and new stroke in minor ischemic stroke or TIA. Neurology. 2018; 90(21):e1870-e1878. (IF=7.7)

105. Pan Y, Jing J, Chen W, Wang Y, He Y*. Associationbetween impaired renal function and stroke outcome in patients with versuswithout atrial fibrillation. Eur JNeurol. 2018; 25(8):1041-1048. (IF=4.5)

106. Wu Y#, Zhou Y#,Pan Y#, Zhao X, LiH, Wang D, Johnston SC, Liu L, Wang C, Meng X, Wang Y*, Wang Y*.Impact of CYP2C19 Polymorphism in Prognosis of Minor Stroke or TIA Patientswith Declined eGFR on Dual Antiplatelet Therapy: CHANCE substudy. Pharmacogenomics J, 2018; 18(6):713-720.(IF=2.9)

107. Pan Y#, Cai X#, Huo X, Zhao X, Liu L, Wang Y, Miao Z*,Wang Y*. Cost-effectiveness of mechanical thrombectomy within 6 hoursof acute ischaemic stroke in China. BMJ Open. 2018;8(2): e018951. (IF=2.4)

108. Pan Y#, Peng Y#, Chen W, Wang Y, Lin Y, He Y*,Wang N*, Wang Y*. THRIVE-c Score Predicts ClinicalOutcomes in Chinese Patients after Thrombolysis. Brain Behav. 2018; 8(2): e00927. (IF=2.6)

109. Zhou M#, Pan Y#, Jing J, WangY, Zhao X, Liu L, Li H, Wang Y*. Association between β-cell functionestimated by HOMA-β and prognosis of non-diabetic patients with ischaemicstroke. Eur J Neurol. 2018;25(3):549-555. (IF=4.5)

110. Pan Y#, Cai X#, Jing J, Meng X, Li H, Wang Y, Zhao X,Liu L, Wang D, Johnston SC, Wei T, Wang Y*. Stress Hyperglycemia andPrognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCEStudy (Clopidogrel in High-Risk Patients With Acute NondisablingCerebrovascular Events). Stroke.2017; 48(11):3006-3011. (IF=7.8)

111. Liu M#, Pan Y#, Zhou L*,Wang Y*. Predictors of post-thrombolysis symptomatic intracranialhemorrhage in Chinese patients with acute ischemic stroke. PLoS One. 2017;12(9):e0184646. (IF=2.9)

112. Pan Y#, Chen W#, JingJ, Zheng H, Jia Q, Li H, Zhao X, Liu L, Wang Y, He Y, Wang Y*. Pancreaticbeta cell function and prognosis of nondiabetic patients with ischemic stroke. Stroke. 2017; 48(11):2999-3005. (IF=7.8)

113. Song T#, Pan Y#, Chen R#,Li H, Zhao X, Liu L, Wang C, Wang Y*, Wang Y*. Is there acorrelation between socioeconomic disparity and functional outcome after acuteischemic stroke? PLoS One. 2017; 12(7):e0181196.(IF=2.9)

114. Wang H#, Pan Y#, Wang C, Liao X, Wang D, Zhao X, Liu L, Li H, Wang Y*, Wang Y*. Validation of the mSOAR and SOAR Scores to Predict EarlyMortality in Chinese Acute Stroke Patients. PLoS One. 2017;12(7):e0180444. (IF=2.9)

115.  Chen W#, Pan Y#, Zhao X, Liu L,Li H, Liao X, Wang C, Wang Y*, Wang Y*. Intravenous thrombolysisin Chinese patients with different subtype of mild stroke. Sci Rep. 2017; 7(1):2299. (IF=3.8)

116.  Pan Y#, Jing J#, Chen W, Meng X, Li H, Zhao X, Liu L, WangD, Johnston SC, Wang Y*, Wang Y*. Risks and benefits ofclopidogrel-aspirin in minor stroke or TIA: time course analysis of CHANCE. Neurology. 2017; 88(20):1906-1911. (IF=7.7)

117. Jing J#, Pan Y#, Zhao X, ZhengH, Jia Q, Mi D, Chen W, Li H, Liu L, Wang C, He Y, Wang D, Wang Y*,Wang Y*. Insulin Resistance and Prognosis ofNondiabetic Patients With Ischemic Stroke The ACROSS-China Study (AbnormalGlucose Regulation in Patients With Acute Stroke Across China). Stroke. 2017; 48(4):887-893.(IF=7.8)

118. Pan Y#, Jing J#, Chen W, Zheng H, Jia Q, Mi D, Li H,Zhao X, Liu L, Wang C, Gaisano HY, He Y*, Wang Y*, Wang Y*.Post-glucose load measures of insulin resistance and prognosis of nondiabetic patientswith ischemic stroke. J Am Heart Assoc. 2017;6(1):e004990. (IF=5.0)

119. Pan Y#, Meng X#, Jing J, Li H, Zhao X, Liu L, Wang D,Johnston SC, Wang Y*, Wang Y*. Association of multipleinfarctions and ICAS with outcomes of minor stroke and TIA. Neurology. 2017; 88(11):1081-1088. (IF=7.7)

120. Pan Y#, Chen W#, Xu Y, Yi X, Han Y, Yang Q, Li X, HuangL, Johnston SC, Zhao X, Liu L, Zhang Q, Wang G, Wang Y*, Wang Y*.Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke ortransient ischemic attack: a systematic review and meta-analysis. Circulation. 2017; 135(1):21-33. (IF=35.5)

121. Sun S#, Pan Y#, Zhao X, Liu L,Li H, He Y, Guo L*, Wang Y*, Wang Y*. The associationbetween impaired glucose regulation and prognosis of Chinese patients with intracerebralhemorrhage. Sci Rep.2016; 6:36220. (IF=3.8)

122. Zhou Y#, Pan Y#, Wu Y#,Zhao X, Li H, Wang D, Johnston SC, Liu L, Wang C, Meng X, Wang Y*,Wang Y*. Effect of Estimated Glomerular Filtration Rate Decline onthe Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke orTransient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk PatientsWith Acute Nondisabling Cerebrovascular Events). Stroke. 2016; 47(11):2791-2796. (IF=7.8)

123.Pan Y#, Chen R*, Li Z, Li H, ZhaoX, Liu L, Wang C, Wang Y*, Wang Y*. Socioeconomic status and thequality of acute stroke care: the China National Stroke Registry. Stroke. 2016; 47(11):2836-2842. (IF=7.8)

124.Sun S#, Pan Y#, Zhao X, LiuL, Li H, He Y, Wang Y*, Wang Y*, Guo L*. Prognosticvalue of admission blood glucose in diabetic and non-diabetic patients with intracerebralhemorrhage. Sci Rep.2016; 6:32342. (IF=3.8)

125.Pan Y#, Jing J, Li H, Wang Y,Wang Y*, He Y*. Abnormal glucose regulation increases strokerisk in minor ischemic stroke or TIA. Neurology.2016; 87(15):1551-1556. (IF=7.7)

126.Jing J#, Pan Y#, Zhao X, ZhengH, Jia Q, Li H, Guan L, Liu L, Wang C, Meng X, He Y, Wang Y*, Wang Y*.Prognosis of ischemic stroke with newly diagnosed diabetes according tohemoglobin A1c criteria in Chinese population. Stroke. 2016;47(8):2038-2044. (IF=7.8)

127.Pan Y#, Wang Y, Li H, GaisanoHY, Wang Y*, He Y*. Association of diabetes and prognosisof minor stroke and its subtypes: a prospective observational study. PLoS One. 2016;11(4):e0153178. (IF=2.9)

128.Pan Y#, Song T#, ChenR*, Li H, Zhao X, Liu L, Wang C, Wang Y*, Wang Y*.Socioeconomic deprivation and mortality in people after ischemic stroke: theChina National Stroke Registry. Int J Stroke. 2016;11(5):557-564. (IF= 6.3)

129.Pan Y, Zhao X, Jiang Y, Li H,Wang L, Liu L, Wang C, Jing J, Xu J, Meng X, Zhang M, Li Y, Zhou Y, Zhao W,Wang Y*, Wang Y*. Prevalence, awareness and control ofhypertension in patients with transient ischemic attacks in China. Neuroepidemiology. 2016;46(2):84-87. (IF=3.2)

130. Wang Y#, Pan Y#, Zhao X, Li H,Wang D, Johnston SC, Liu L, Meng X, Wang A, Wang C, Wang Y*.Clopidogrel with aspirin in acute minor stroke or transient ischemic attack(CHANCE): 1-year outcomes. Circulation.2015;132(1):40-46. (IF=35.5)

131. Chen W#,Pan Y#, Zhao X,Liao X, Liu L, Wang C, Wang Y*, Wang Y*. Totaled Health Risks inVascular Events score predicts clinical outcome and symptomatic intracranial hemorrhagein Chinese patients after thrombolysis. Stroke. 2015;46(3):864-866. (IF=7.8)

132. Pan Y#, Chen Q#,Liao X, Zhao X, Wang C, Liu G, Liu L, Wang C, Wang D, Wang Y*, WangY*. Preexisting dual antiplatelet treatment increases the risk ofpost-thrombolysis intracranial hemorrhage in Chinese stroke patients. Neurol Res. 2015;37(1):64-68.(IF=1.7)

133. Wang YL#,Pan YS#, Zhao XQ,Wang D, Johnston SC, Liu LP, Meng X, Wang AX, Wang CX, Wang YJ*. Recurrent stroke was associatedwith poor quality of life in patients with TIA or minor stroke: finding fromthe CHANCE trial. CNSNeurosci Ther. 2014; 20(12):1029-1035. (IF=4.8)

134. Pan Y#, Chen Q#,Zhao X, Liao X, Wang C, Du W, Liu G, Liu L, Wang C, Wang Y*, Wang Y*.Cost-effectivenessof thrombolysis within 4.5 hours of acute ischemic stroke in China. PLoS One. 2014;9(10):e110525. (IF=2.9)

135. Pan Y, Jing J, ZhangR, Zhao X, Liu L, Wang H, Liu G, Wang C, Wang Y*, Wang Y*.Poor performanceof stroke prognostication using Age and National Institutes of Health StrokeScale-100 to predict 3- and 12-month outcomes of ischemic stroke in ChinaNational Stroke Registry. J StrokeCerebrovasc Dis. 2014;23(9):2335-2340. (IF=2.0)

136.  Pan Y#, Wang A#, Liu G, Zhao X, Meng X, Zhoa K, Liu L,Wang C, Johnston C, Wang Y*, Wang Y*. Cost–effectivenessof clopidogrel-aspirin versus aspirin alone for acute TIA and minor stroke. J Am Heart Assoc. 2014;3(3):e000912. (IF=5.0)

137.  Pan YS#, Jing J#, Wang YL, Zhao XQ, Song B, Wang WJ, WangD, Liu GF, Liu LP, Wang CX, Wang YJ*. Use of statin during hospitalizationimproves the outcome after intracerebral hemorrhage. CNS Neurosci Ther. 2014; 20(6):548–555. (IF=4.8)

成果获奖：

1. “脑血管病医疗质量改进关键技术与体系的建立和应用”2020年获国家科学技术进步奖二等奖(排名第8),授予机构：国务院

2.“急性缺血性卒中精准防治关键技术及应用”2025教育部科学研究优秀成果奖特等奖（排名第8），授予机构：教育部

3.“成人颅内动脉粥样硬化高分辨磁共振精准评估研究及应用”2024年获浙江省科学技术进步奖三等奖 (排名第2),授予机构：浙江省人民政府

4. “灌注CT指导下的缺血性脑卒中的动脉溶栓取栓治疗”2019年获浙江省科学技术进步奖三等奖 (排名第3),授予机构：浙江省人民政府